(Q56920288)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10646090%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10646090%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Girard M

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10646090%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Habel A

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10646090%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Chanel C

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10646090%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10646090%20AND%20SRC:MED&resulttype=core&format=json

Comptes rendus de l'Académie des sciences. Série 3, Sciences de la vie

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10646090%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

322

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10646090%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

959-966

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10646090%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10646090%20AND%20SRC:MED&resulttype=core&format=json

Study of the V3 loop as a target epitope for antibodies involved in the neutralization of primary isolates versus T-cell-line-adapted strains of human immunodeficiency virus type 1

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Macaque models for AIDS vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Inhibition of simian immunodeficiency virus (SIV) replication by CD8(+) T lymphocytes from macaques immunized with live attenuated SIV

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

CD8-suppressor factor and beta-chemokine function as a complementary mechanism to cognate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Toward an understanding of the correlates of protective immunity to HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA.

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp 160 of HIV-1 and boosted with a recombinant gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Alphavirus expression vectors and their use as recombinant vaccines: a minireview.

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Two-helper RNA system for production of recombinant Semliki forest virus particles.

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canarypox vector (ALVAC) carrying the HIV-1MN env gene

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Manipulation of the Semliki Forest virus genome and its potential for vaccine construction

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Infective and anti-infective properties of breastmilk from HIV-1-infected women.

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

The HIV-1 Tat protein: an RNA sequence-specific processivity factor?

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

HIV-1 Tat protein as a potential AIDS vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

EF-G-dependent GTP hydrolysis induces translocation accompanied by large conformational changes in the 70S ribosome

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Optimization of live oral Salmonella-HIV-1 vaccine vectors for the induction of HIV-specific mucosal and systemic immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

Fusion-competent vaccines: broad neutralization of primary isolates of HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0764-4469%2800%2987193-0

7 January 2021

10.1016/S0764-4469(00)87193-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10646090%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference